Skip to content
NeuroTechGuide

Axoft reports early human recordings with its soft Fleuron brain probes

The company says short-term recordings in 12 surgical patients in Boston and Panama showed stable, high-yield signals, presented at three fall neuroscience meetings.

In briefImplantsResearch

Axoft, a Cambridge, Massachusetts start-up, said on November 19 that it has presented short-term human recordings from its ultra-soft Fleuron depth probes at three fall meetings. At The Panama Clinic, five people were briefly implanted to test whether cortical signals could classify anesthetic state. In seven more patients at Mass General Brigham and The Panama Clinic, probes were placed during planned tumor or hematoma surgery; the company says up to 85% of channels picked up single-neuron spikes. A third presentation, at the Society for Neuroscience meeting, compared pig and human data on whether the probes move with the brain.

All results are company-reported conference data from acute, intraoperative use, not peer-reviewed and not long-term implants. Axoft says it is targeting disorders of consciousness first.

Learn more: Microelectrode array · Axoft in the Directory · Axoft’s $55M Series A

Share:XLinkedInBlueskyEmail

More news